16:44 JST, October 5, 2022
MOSCOW (AP) — Three Russian cosmonauts returned safely Sept. 29 from a mission to the International Space Station.
The Soyuz MS-21 spacecraft carrying Oleg Artemyev, Denis Matveyev and Sergey Korsakov touched down softly at 4:57 p.m. at a designated site in the steppes of Kazakhstan, 150 kilometers southeast of the city of Zhezkazgan.
The trio had arrived at the space station in March. For Artemyev, the mission marked a third space flight, bringing his total time spent in orbit to 561 days. Matveyev and Korsakov each logged 195 days on their first missions.
As the Soyuz capsule was descending, using a big striped red-and-white parachute under clear skies, Artemyev reported to Mission Control that all members of the crew were feeling fine.
Helicopter support teams landed minutes after their landing to recover the space crew. After a quick post-flight medical exam, the cosmonauts were flown to the Star City cosmonaut training center outside Moscow.
The space station is currently being operated by Samantha Cristoforetti of the European Space Agency, NASA astronauts Bob Hines, Kjell Lindgren, Frank Rubio and Jessica Watkins, and the Russian space agency Roscosmos cosmonauts Sergey Prokopyev and Dmitri Petelin.
Top Articles in Science & Nature
-
iPS Treatments Pass Key Milestone, but Broader Applications Far from Guaranteed
-
Record 700 Startups to Gather at SusHi Tech Tokyo in April; Event Will Center on Themes Like Artificial Intelligence and Robotics
-
Parents in Japan to Get Instagram Notifications When Teens Repeatedly Search for Suicide Content
-
iPS Cell Products for Parkinson’s, Heart Disease OK’d for Commercialization by Japan Health Ministry Panel
-
Japan to Ban Use of Power Banks on Airplanes
JN ACCESS RANKING
-
Producer Behind Pop Group XG Arrested for Cocaine Possession
-
Japan PM Takaichi’s Cabinet Resigns en Masse
-
Man Infected with Measles Reportedly Dined at Restaurant in Tokyo Station
-
Japan Figure Skating Legend Yuzuru Hanyu Is Proud Disaster Survivor and Gold Medalist, Vows to Continue Support Efforts
-
iPS Treatments Pass Key Milestone, but Broader Applications Far from Guaranteed

